Longitudinal clinical and pathological progression across amyloid and tau PET–based Alzheimer’s disease biological stages

Karly Cody1, Andrzej Sokolowski1, Joseph Winer1, Kyan Younes1, Alaina Durant2, Logan Dumitrescu2, Derek Archer2, Sid O’Bryant3, Robert Barber3, Duygu Tosun4, Theresa M. Harrison5, Mary Ellen Koran6, Timothy Hohman2, Elizabeth Mormino1

Author affiliations:
1. Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA
2. Vanderbilt Memory and Alzheimer’s Center, Vanderbilt Genetics Institute, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
3. University of North Texas Health Institute for Translational Research, Fort Worth, TX, USA
4. Department of Radiology, University of California-San Francisco, San Francisco, CA, USA
5. Neuroscience Department, University of California-Berkeley, CA, USA
6. Mayo Clinic, Scottsdale, AZ, USA